Upstream Bio, Inc. logo UPB - Upstream Bio, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 1
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $33.00 DETAILS
HIGH: $51.00
LOW: $15.00
MEDIAN: $33.00
CONSENSUS: $33.00
UPSIDE: 294.27%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3
Revenue
Revenue 1.0 0.7 0.7 0.9 0.6 0.6 0.6 0.5 0.6 0.5 0.6
Cost of Revenue 0.0 0 0 0 0 0 0 0 0 0 0
Gross Profit 1.0 0.7 0.7 0.9 0.6 0.6 0.6 0.5 0.6 0.5 0.6
Operating Expenses
R&D Expenses 36.6 40.2 33.0 37.9 25.8 21.8 15.4 14.1 11.7 11.6 7.8
SG&A Expenses 8.1 6.7 5.5 7.4 6.8 5.2 4.1 4.0 4.0 3.2 2.2
Other Expenses (0.0) 0 0 0 0 0 0 0 0 0 0
Operating Expenses 44.6 46.8 38.5 45.3 32.6 26.9 19.5 18.1 15.7 14.8 10.0
Operating Income
Operating Income (43.6) (46.2) (37.8) (44.3) (32.0) (26.3) (18.9) (17.5) (15.0) (14.3) (9.4)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0
Interest Income 3.1 3.7 4.1 4.4 4.7 5.1 2.9 2.9 1.3 1.5 1.5
Profitability
EBITDA (43.6) (46.1) (37.8) (44.3) (32.0) (26.3) (18.9) (17.5) (15) (14.3) (9.4)
EBIT (43.6) (46.2) (37.8) (44.3) (32.0) (26.3) (18.9) (17.5) (15.0) (14.3) (9.4)
Income Before Tax (40.6) (42.5) (33.7) (40.0) (27.3) (21.2) (16.0) (14.7) (10.9) (11.8) (3.1)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0
Net Income (40.6) (42.5) (33.7) (40.0) (27.3) (21.2) (16.0) (14.7) (10.9) (11.8) (3.1)
Per Share Data
EPS (Basic) -0.75 -0.79 -0.63 -0.74 -0.51 -0.41 -0.41 -0.38 -0.27 -0.41 -0.17
EPS (Diluted) -0.75 -0.79 -0.63 -0.74 -0.51 -0.41 -0.41 -0.38 -0.27 -0.41 -0.17
Shares Outstanding 54.3 54.2 53.9 53.8 53.6 51.3 51.3 51.3 51.3 36.3 36.3
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4
Current Assets
Cash & Cash Equivalents 96.7 101.6 72.2 45.5 71.3 325.9 32.9 47.3 0 25.8
Short-Term Investments 197.9 239.9 300.3 348.1 360.1 144.6 187.7 188.5 0 84.0
Net Receivables 1.0 0.7 0.7 2.6 1.7 1.2 1.1 0.9 0 0.2
Inventory 0 0 0 0 0 0 0 0 0 0
Other Current Assets 20.7 9.6 15.9 0.8 1 0.5 0.4 0.6 (109.8) 0.4
Total Current Assets 316.3 351.8 389.0 418.3 453.8 479.2 227.3 243.0 0 117.0
Non-Current Assets
Property, Plant & Equipment 1.6 1.8 2.0 2.1 2.2 2.4 2.5 0.1 0 0.2
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0.2 0 0 0 0 0 0
Other Non-Current Assets 0.2 0.2 0.2 0 0.2 0.2 2.9 1.3 0 0
Total Non-Current Assets 1.8 2.0 2.2 2.2 2.4 2.6 5.4 1.5 0 0.2
Total Assets 318.1 353.8 391.2 420.5 456.2 481.7 232.7 244.5 0 117.2
Current Liabilities
Account Payables 1.7 2.7 4.0 2.6 4.7 4.0 4.9 5.6 0 2.0
Short-Term Debt 0.7 0.7 0.7 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 11.2 10.0 7.2 1.9 0.9 2.7 2.1 1.6 0 2.2
Total Current Liabilities 13.7 13.5 11.9 10.9 9.6 10.7 10.9 10.2 0 6.5
Non-Current Liabilities
Long-Term Debt 0.4 0.5 0.7 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 380.9 380.9 (107.8) 233.8
Total Non-Current Liabilities 0.4 0.5 0.7 0.8 1.0 1.1 382.1 380.9 (107.8) 233.8
Total Liabilities 14.1 14.0 12.6 11.8 10.6 11.9 393.0 391.1 (107.8) 240.3
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0 0.0
Retained Earnings (374.8) (334.2) (291.8) (258.0) (218.1) (190.8) (169.5) (153.5) 0 (128.0)
Accumulated Other Comprehensive Income 0.1 0.5 0.5 0.3 0.4 (0.0) 0.4 (0.1) (123.1) 0.0
Total Stockholders' Equity 304.0 339.8 378.6 408.7 445.6 469.9 (160.3) (146.6) 107.8 (123.1)
Total Liabilities & Equity 318.1 353.8 391.2 420.5 456.2 481.7 232.7 244.5 0 117.2
Debt Metrics
Total Debt 1.1 1.3 1.4 1.6 1.7 1.8 1.9 0 0 0.0
Net Debt (95.6) (100.3) (70.7) (43.9) (69.6) (324.1) (31.0) (47.3) 0 (25.8)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3
Operating Activities
Net Income (40.6) (42.5) (33.7) (40.0) (27.3) (21.2) (16.0) (14.7) (10.9) (11.8) (3.1)
Depreciation & Amortization (0.7) 5.9 (2.8) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 4.6 2.5 2.6 2.6 2.6 2.1 1.9 1.4 0.6 0.8 0.7
Change in Working Capital (11.4) 7.7 8.9 (1.1) (15.0) (1.3) 0.7 6.3 (3.9) (4.0) 3.1
Other Non-Cash Items 0.2 (4.3) 2.9 (0.8) (1.6) 0.8 (0.6) (1.1) (3.5) (1.1) (5.5)
Operating Cash Flow (47.9) (30.6) (22.2) (39.2) (41.2) (19.6) (14.0) (8.0) (17.6) (16.1) (4.8)
Investing Activities
Capital Expenditure 0 (0.0) 0.0 (0.0) 0 (0.2) (0.3) 0 0 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (14.4) (38.3) (24.5) (57.1) (266.1) (42.2) (73.4) (151.6) (23.4) (34.8) (4.5)
Sales/Maturities of Investments 56.8 97.3 72.7 69.9 52.7 84.3 75.1 34.9 37.3 29.6 16.7
Other Investing Activities 0 (0.0) (0.1) 0 0 0 0 0 0 0 0
Investing Cash Flow 42.4 58.9 48.2 12.8 (213.4) 41.9 1.4 (116.7) 13.9 (5.2) 12.2
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 0 (1.6) 140.5 9.4 0 0.1
Financing Cash Flow 0.6 1.1 0.8 0.6 (0.0) 270.6 (1.6) 140.5 9.4 (0.1) 0.1
Cash Position
Net Change in Cash (4.9) 29.4 26.7 (25.9) (254.6) 292.9 (14.2) 15.8 5.7 (21.5) 7.5
Cash at Beginning 101.8 72.4 45.7 71.5 326.1 33.1 47.3 31.5 25.8 47.3 39.8
Cash at End 96.9 101.8 72.4 45.7 71.5 326.1 33.1 47.3 31.5 25.8 47.3
Free Cash Flow (47.9) (30.7) (22.2) (39.3) (41.2) (19.8) (14.3) (8.0) (17.6) (16.1) (4.8)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3
Income Statement
Revenue 1.0 0.7 0.7 0.9 0.6 0.6 0.6 0.5 0.6 0.5 0.6
Gross Profit 1.0 0.7 0.7 0.9 0.6 0.6 0.6 0.5 0.6 0.5 0.6
Operating Income (43.6) (46.2) (37.8) (44.3) (32.0) (26.3) (18.9) (17.5) (15.0) (14.3) (9.4)
Net Income (40.6) (42.5) (33.7) (40.0) (27.3) (21.2) (16.0) (14.7) (10.9) (11.8) (3.1)
EPS (Diluted) -0.75 -0.79 -0.63 -0.74 -0.51 -0.41 -0.41 -0.38 -0.27 -0.41 -0.17
Balance Sheet
Cash & Equivalents 96.7 101.6 72.2 45.5 71.3 325.9 32.9 47.3 0 25.8
Total Assets 318.1 353.8 391.2 420.5 456.2 481.7 232.7 244.5 0 117.2
Total Debt 1.1 1.3 1.4 1.6 1.7 1.8 1.9 0 0 0.0
Stockholders' Equity 304.0 339.8 378.6 408.7 445.6 469.9 (160.3) (146.6) 107.8 (123.1)
Cash Flow
Operating Cash Flow (47.9) (30.6) (22.2) (39.2) (41.2) (19.6) (14.0) (8.0) (17.6) (16.1) (4.8)
Capital Expenditure 0 (0.0) 0.0 (0.0) 0 (0.2) (0.3) 0 0 0 0
Free Cash Flow (47.9) (30.7) (22.2) (39.3) (41.2) (19.8) (14.3) (8.0) (17.6) (16.1) (4.8)